射频消融治疗肝细胞癌骨转移：病例报告
Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: case report.
作者信息
Maruyama Michihiro, Asano Takehide, Kenmochi Takashi, Kainuma Osamu, Iwasaki Kotaro, Miyauchi Hideaki, Saigo Kenichi, Miura Fumihiko, Kobayashi Susumu, Ochiai Takenori
机构信息
Second Department of Surgery, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-0877 Japan.
出版信息
Anticancer Res. 2003 May-Jun;23(3C):2987-9.
BACKGROUND
Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC.
CASE
A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA.
CONCLUSION
RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.
背景
射频消融（RFA）是肝细胞癌（HCC）的标准经皮治疗方法之一，但RFA尚未应用于治疗HCC的骨转移。
病例
一名65岁男性患者，两年半前因HCC接受了肝切除术，现主诉右大腿疼痛。影像学检查和针吸活检显示其右髋臼有转移性HCC。首次RFA治疗在计算机断层扫描（CT）引导下进行，并联合42 Gy放射治疗。首次RFA治疗4年后，因盆腔肿瘤复发进行了第二次RFA治疗。
结论
RFA是一种安全、简便、可重复且有效的治疗方法，应成为HCC骨转移最重要的治疗方式之一。
Zotero 插件